Integrated miRNA profiling and bioinformatics analyses reveal potential causative miRNAs in gastric adenocarcinoma

Oncotarget

Volumn 6, Issue 32, 2015, Pages 32878-32889

  Zhang, Xiaojing ^a   Peng, Yin ^a,e   Jin, Zhe ^a,c   Huang, Weiling ^a   Cheng, Yulan ^b   Liu, Yudan ^d   Feng, Xianling ^a   Yang, Mengting ^a   Huang, Yong ^a   Zhao, Zhenfu ^a   Wang, Liang ^a   Wei, Yanjie ^f   Fan, Xinmin ^a   Zheng, Duo ^a   Meltzer, Stephen J ^b  

^a Shenzhen University School of Medicine   (China)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PEKING UNIVERSITY   (China)

^d CHINA MEDICAL UNIVERSITY   (China)

^e WUHAN UNIVERSITY   (China)

^f SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY   (China)

Author keywords

Bioinformatics; Gastric cancer; MiRNA profiling

Indexed keywords

MICRORNA; MICRORNA 100; MICRORNA 106A; MICRORNA 125B; MICRORNA 127 3P; MICRORNA 145; MICRORNA 17; MICRORNA 193A; MICRORNA 20A; MICRORNA 381; MICRORNA 92A; MICRORNA 96; MITOGEN ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; TUMOR MARKER;

APOPTOSIS; ARTICLE; BINDING SITE; BIOINFORMATICS; CARCINOGENESIS; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; RNA ANALYSIS; RNA BINDING; SIGNAL TRANSDUCTION; STOMACH ADENOCARCINOMA; UPREGULATION; VALIDATION PROCESS; ADENOCARCINOMA; BIOLOGY; GENETIC PREDISPOSITION; GENETICS; PATHOLOGY; PHENOTYPE; PREDICTIVE VALUE; PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; STOMACH NEOPLASMS;

ADENOCARCINOMA; BIOMARKERS, TUMOR; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICRORNAS; PHENOTYPE; PREDICTIVE VALUE OF TESTS; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS;

EID: 84946027741     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.5419     Document Type: Article

References (36)

1. Lv SX, Gan JH, Wang CC, Luo EP, Huang XP, Xie Y, Huang Y. Biopsy from the base of gastric ulcer may find gastric cancer earlier. Med Hypotheses. 2011; 76:249-250.
2. Tang L, Zhao S, Liu W, Parchim NF, Huang J, Tang Y, Gan P, Zhong M. Diagnostic accuracy of circulating tumor cells detection in gastric cancer: systematic review and metaanalysis. BMC cancer. 2013; 13:314.
3. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009; 136:215-233.
4. Lujambio A, Lowe SW. The microcosmos of cancer. Nature. 2012; 482:347-355.
5. Li X, Zhang Y, Zhang Y, Ding J, Wu K, Fan D. Survival prediction of gastric cancer by a seven-microRNA signature. Gut. 2010; 59:579-585.
6. Ueda T, Volinia S, Okumura H, Shimizu M, Taccioli C, Rossi S, Alder H, Liu CG, Oue N, Yasui W, Yoshida K, Sasaki H, Nomura S, Seto Y, Kaminishi M, Calin GA, et al. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol. 2010; 11:136-146.
7. Carvalho J, van Grieken NC, Pereira PM, Sousa S, Tijssen M, Buffart TE, Diosdado B, Grabsch H, Santos MA, Meijer G, Seruca R, Carvalho B, Oliveira C. Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 upregulation in intestinal gastric cancer. J Pathol. 2012; 228:31-44.
8. Tsukamoto Y, Nakada C, Noguchi T, Tanigawa M, Nguyen LT, Uchida T, Hijiya N, Matsuura K, Fujioka T, Seto M, Moriyama M. MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer Res. 2010; 70:2339-2349.
9. Labi V, Erlacher M. How cell death shapes cancer. Cell death & disease. 2015; 6:e1675.
10. Leonardo TR, Schultheisz HL, Loring JF, Laurent LC. The functions of microRNAs in pluripotency and reprogramming. Nat Cell Biol. 2012; 14:1114-1121.
11. van Rooij E, Olson EN. MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles. Nat Rev Drug Discov. 2012; 11:860-872.
12. Nana-Sinkam SP, Croce CM. Clinical applications for microRNAs in cancer. Clin Pharmacol Ther. 2013; 93:98-104.
13. Li P, Xu Q, Zhang D, Li X, Han L, Lei J, Duan W, Ma Q, Wu Z, Wang Z. Upregulated miR-106a plays an oncogenic role in pancreatic cancer. FEBS Lett. 2014; 588:705-712.
14. Cui L, Zhang X, Ye G, Zheng T, Song H, Deng H, Xiao B, Xia T, Yu X, Le Y, Guo J. Gastric juice MicroRNAs as potential biomarkers for the screening of gastric cancer. Cancer. 2013; 119:1618-1626.
15. Zhu M, Zhang N, He S, Lui Y, Lu G, Zhao L. MicroRNA-106a targets TIMP2 to regulate invasion and metastasis of gastric cancer. FEBS Lett. 2014; 588:600-607.
16. Kim BH, Hong SW, Kim A, Choi SH, Yoon SO. Prognostic implications for high expression of oncogenic microRNAs in advanced gastric carcinoma. J Surg Oncol. 2013; 107:505-510.
17. Kim YK, Yu J, Han TS, Park SY, Namkoong B, Kim DH, Hur K, Yoo MW, Lee HJ, Yang HK, Kim VN. Functional links between clustered microRNAs: suppression of cellcycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res. 2009; 37:1672-1681.
18. Guo J, Miao Y, Xiao B, Huan R, Jiang Z, Meng D, Wang Y. Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol. 2009; 24:652-657.
19. Fassan M, Pizzi M, Realdon S, Balistreri M, Guzzardo V, Zagonel V, Castoro C, Mastracci L, Farinati F, Nitti D, Zaninotto G, Rugge M. The HER2-miR125a5p/miR125b loop in gastric and esophageal carcinogenesis. Hum Pathol. 2013; 44:1804-1810.
20. Guo LH, Li H, Wang F, Yu J, He JS. The Tumor Suppressor Roles of miR-433 and miR-127 in Gastric Cancer. Int J Mol Sci. 2013; 14:14171-14184.
21. Qiu T, Zhou X, Wang J, Du Y, Xu J, Huang Z, Zhu W, Shu Y, Liu P. MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer. FEBS Lett. 2014; 588:1168-1177.
22. Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science. 2002; 298:1911-1912.
23. Zhang Z, Miao L, Xin X, Zhang J, Yang S, Miao M, Kong X, Jiao B. Underexpressed CNDP2 participates in gastric cancer growth inhibition through activating the MAPK signaling pathway. Mol Med. 2014; 20:17-28.
24. Liang B, Wang S, Zhu XG, Yu YX, Cui ZR, Yu YZ. Increased expression of mitogen-activated protein kinase and its upstream regulating signal in human gastric cancer. World J Gastroenterol. 2005; 11:623-628.
25. Jia HY, Wang YX, Yan WT, Li HY, Tian YZ, Wang SM, Zhao HL. MicroRNA-125b Functions as a Tumor Suppressor in Hepatocellular Carcinoma Cells. Int J Mol Sci. 2012; 13:8762-8774.
26. Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP, Liu CG, Bhatt D, Taccioli C, Croce CM. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA. 2007; 297:1901-1908.
27. Shi XB, Xue L, Yang J, Ma AH, Zhao J, Xu M, Tepper CG, Evans CP, Kung HJ, deVere White RW. An androgenregulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells. Proc Natl Acad Sci U S A. 2007; 104:19983-19988.
28. Bousquet M, Quelen C, Rosati R, Mansat-De Mas V, La Starza R, Bastard C, Lippert E, Talmant P, Lafage-PochitaloffM, Leroux D, Gervais C, Viguie F, Lai JL, Terre C, Beverlo B, Sambani C, et al. Myeloid cell differentiation arrest by miRNA-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t(2,11)(p21;q23) translocation. J Exp Med. 2008; 205:2499-2506.
29. Wu JG, Wang JJ, Jiang X, Lan JP, He XJ, Wang HJ, Ma YY, Xia YJ, Ru GQ, Ma J, Zhao ZS, Zhou R. MiRNA-125b promotes cell migration and invasion by targeting PPP1CA-Rb signal pathways in gastric cancer, resulting in a poor prognosis. Gastric Cancer. 2014.
30. Huang K, Dong S, Li W, Xie Z. The expression and regulation of microRNA-125b in cancers. Acta Biochim Biophys Sin (Shanghai). 2013; 45:803-805.
31. Vriens MR, Weng J, Suh I, Huynh N, Guerrero MA, Shen WT, Duh QY, Clark OH, Kebebew E. MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer. Cancer. 2012; 118:3426-3432.
32. Pallante P, Visone R, Ferracin M, Ferraro A, Berlingieri MT, Troncone G, Chiappetta G, Liu CG, Santoro M, Negrini M, Croce CM, Fusco A. MicroRNA deregulation in human thyroid papillary carcinomas. Endocr Relat Cancer. 2006; 13:497-508.
33. Wu N, Lin X, Zhao X, Zheng L, Xiao L, Liu J, Ge L, Cao S. MiRNA-125b acts as an oncogene in glioblastoma cells and inhibits cell apoptosis through p53 and p38MAPK-independent pathways. Br J Cancer. 2013; 109:2853-2863.
34. Jin Z, Selaru FM, Cheng Y, Kan T, Agarwal R, Mori Y, Olaru AV, Yang J, David S, Hamilton JP, Abraham JM, Harmon J, Duncan M, Montgomery EA, Meltzer SJ. MicroRNA-192 and-215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro. Oncogene. 2011; 30:1577-1585.
35. Sam LT, Mendonca EA, Li J, Blake J, Friedman C, Lussier YA. PhenoGO: an integrated resource for the multiscale mining of clinical and biological data. BMC Bioinformatics. 2009; 10:S8.
36. Dweep H, Sticht C, Pandey P, Gretz N. miRWalk-database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. J Biomed Inform. 2011; 44:839-847.